Heineken (OTCMKTS:HEINY) Upgraded at Zacks Investment Research

Share on StockTwits

Zacks Investment Research upgraded shares of Heineken (OTCMKTS:HEINY) from a sell rating to a hold rating in a report published on Wednesday morning, Zacks.com reports.

According to Zacks, “Heineken N.V. is engaged in producing and distributing beverages. It offers beer, cider, soft drinks, and other beverages. The Company’s principal global brand is Heineken. Heineken N.V. is headquartered in Amsterdam, the Netherlands. “

OTCMKTS:HEINY opened at $53.45 on Wednesday. Heineken has a one year low of $42.76 and a one year high of $57.84. The company has a debt-to-equity ratio of 0.81, a quick ratio of 0.68 and a current ratio of 0.87. The firm has a market cap of $61.89 billion, a P/E ratio of 21.29, a P/E/G ratio of 3.02 and a beta of 0.70. The firm has a 50-day simple moving average of $53.25 and a 200-day simple moving average of $53.85.

About Heineken

Heineken N.V. engages in brewing and selling beer and cider. The company operates through Africa, Middle East & Eastern Europe; Americas; Asia Pacific; and Europe segments. It offers beer, cider, soft drinks, and other beverages. The company offers its beers under the Heineken, Amstel, Desperados, Sol, Tiger, Tecate, Red Stripe, KruĀšovice, Birra Morett, Affligem, Lagunitas, and Mort Subite brands, as well as under various other regional and local brands; and cider under the Strongbow Apple Ciders, Orchard Thieves, Stassen, Bulmers, Old Mout, and Blind Pig brands.

Featured Article: How to Invest in Stocks with Increasing Dividends

Get a free copy of the Zacks research report on Heineken (HEINY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Heineken (OTCMKTS:HEINY)

Receive News & Ratings for Heineken Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heineken and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.